Lumateperone (ITI-007)

lumateperone · Intra-Cellular Therapies, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lumateperone (ITI-007), covering 2017-03-10 to 2025-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of a Novel Antipsychotic ITI-007 in Schizophrenia [Phase 2]